Wyss Institute for Biologically Inspired Engineering

The Wyss Institute for Biologically Inspired Engineering (pronounced /viːs/ "veese") is a cross-disciplinary research institute at Harvard University focused on bridging the gap between academia and industry (translational medicine) by drawing inspiration from nature's design principles to solve challenges in health care and the environment.

Ingber became the founding director of the Wyss Institute and David Mooney became a founding Core Faculty member, along with Professors Joanna Aizenberg, David A. Edwards, Kit Parker, George M. Whitesides, George Church, Ary Goldberger, William Shih, Robert Wood, James J. Collins, L. Mahadevan, Radhika Nagpal, and Pamela Silver.

The funding was used to further the institute's interdisciplinary research, which includes DNA engineering, cleaning toxins from blood, vibrating insoles to help older adults maintain balance, and a melanoma cancer vaccine.

The $12 million funding supports research related to RNA therapies, genome engineering, and new drug delivery methods.

[52] The identification of undocumented nucleic acid contamination during routine experiments, which inadvertently caused false positives for COVID-19,[53] led to the development of new safety protocols to protect researchers and ensure data integrity.

Hansjörg Wyss , benefactor of the Wyss Institute
Lung-on-a-Chip, as developed by the Wyss Institute
U.S. Army evaluates DARPA's futuristic soft exosuit, originated at the Wyss Institute